摘要: The clustering of abnormal laboratory test data and body measurements, listed in 1, encompassing parameters that should be measured on a regular basis physician offices, collectively referred to as “The Metabolic Syndrome” represents an important risk stratification determination with its awareness applicability primary care increasing worldwide. A recent review found greater than 66% physicians consider this syndrome the diagnosis, treatment, management their patients. These felt 20% patients had metabolic over 94% expecting diagnosed increase within near future [1].